Advocacy Actions

2019-12-27 > Beijing

Attended the Artificial Intelligence Medical Device Innovation and Cooperation Platform

On 27 December, COCIR Representative and several member companies attended the Artificial Intelligence Medical Device Innovation and Cooperation Platform.

Read more
2019-12-23 > Beijing

Follow-up Advocacy Letter to the National Medical Products Administration on the Registration and Administration of Blood Screening IVD Products

On 23rd December, the medical devices sector submitted an advocacy letter to the National Medical Products Administration on the registration and administration of blood screening In Vitro Diagnosis products as the follow-up action of the advocacy letter sent on 19th September.

Read more
2019-12-17 > Beijing

Comments to the NDRC's Draft 'Ammendment of the Tender Law'

The Public Procurement Taskforce submitted comments to the National Development and Reform Commission's (NDRC's) draft 'Amendment to Tender Law of the PR China'.

Read more
2019-12-12 > All chapters

Survey on access to standardisation activities

From 2nd to 12th December, the Standards and Conformity Assessment Working Group, along with other relevant Working Groups, launched a survey to better understand the issues with access to standardisation activities of European businesses.

Read more
2019-12-09 > Beijing

Comments to the CMDE's draft "Technical Review Guideline for Modification of Registrations of IVD"

The Healthcare Equipment (HCE) Working Group submitted comments to the Centre of Medical Device Evaluation's (CMDE's) draft "Technical Review Guideline for Modification of Registrations of in-vitro diagnostics (IVD)".

Read more
2019-12-09 > Beijing, South China

Recommendations to Guangdong HSA's draft "Guideline on Promoting Group Procurement of Drug and Consumable Medical Devices"

The Healthcare Equipment Working Group submitted recommendations to the Guangdong Healthcare Security Administration's (HSA's) draft "Guideline on Promoting Group Procurement of Drug and Consumable Medical Devices".

Read more
2019-12-06 > Beijing

Meeting with the Center for Medical Device Evaluation on the Technical Guideline on Examining the Function of Qualitative Testing Reagents (Draft for Public Consultation).

On 6th December, the Center for Medical Device Evaluation organized a meeting on the Technical Guideline on Examining the Function of Qualitative Testing Reagents (Draft for Public Consultation).

Read more
2019-12-06 > Beijing

Meeting with the Center for Medical Device Evaluation on the Technical Review Guideline for Quantitative Testing Reagent Performance Assessment Registration (Draft for Public Consultation)

On 6th December, the Center for Medical Device organized a meeting on the Technical Review Guideline for Quantitative Testing Reagent Performance Assessment Registration (Draft for Public Consultation).

Read more
2019-12-03 > Beijing

Meeting wiith DG Grow on Public Procurement in the Medical Device Industry

The Healthcare Equipment (HCE) Working Group and the Public Procurement Taskforce met with the Access to Procurement Markets Unit of DG GROW on challenges of European Companies in China's public market with a focus on the medical device market.

Read more
2019-11-26 > Beijing

Comments to the CMDE's Public Consultation on the Guideline on Supplementary Materials for Medical Equipment Registration and Assessment (Draft for Comments)

On 26th November, the medical device submitted comments to the Center for Medical Device Evaluation on it s public consultation on the Guideline on Supplementary Materials for Medical Equipment Registration and Assessment (Draft for Comments).

Read more